Journals / The Anatolian Journal of Cardiology / 2016 / Cilt: 16 - Sayı: 4

The value of coronary artery calcium score in the early diagnosis of coronary artery disease in patients with stable chronic obstructive pulmonary disease

Pages
283–289
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Male stage II COPD patients with a disease duration of 10 years, physical inactivity, and/or a positive family history should be monitored for early stage coronary artery disease and coronary events, regardless of risk factors such as diabetes, hypertension, and hyperlipidemia

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Our aim was to assess the value of coronary artery calcium score (CACS) in the early diagnosis of coronary artery disease in Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage II chronic obstructive pulmonary disease (COPD) patients and to identify high-risk patients.Methods: Forty-two patients with GOLD stage II COPD and 31 healthy control subjects were enrolled in the study.
📊
Key Findings & Data:Criteria for stage II COPD diagnosis were forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) of <70% and 50%<=FEV1<80%.
💡
Conclusion & Impact:Male stage II COPD patients with a disease duration of 10 years, physical inactivity, and/or a positive family history should be monitored for early stage coronary artery disease and coronary events, regardless of risk factors such as diabetes, hypertension, and hyperlipidemia
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Our aim was to assess the value of coronary artery calcium score (CACS) in the early diagnosis of coronary artery disease in Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage II chronic obstructive pulmonary disease (COPD) patients and to identify high-risk patients.Methods: Forty-two patients with GOLD stage II COPD and 31 healthy control subjects were enrolled in the study. This study was designed as a prospective observational cross-sectional study. Pearson's correlation coefficient was used for comparisons between groups. Criteria for stage II COPD diagnosis were forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) of <70% and 50%<=FEV1<80%. Excluded from the study were individuals who had a previous diagnosis of coronary artery disease, GOLD stage I-III-IV COPD, or left ventricular systolic dysfunction.Results: As compared with the control group, CACS values were significantly higher in the patient group (p=0.030 and 0.001, respectively). CACS was significantly higher in male patients with a positive family history, physical inactivity, long duration of disease, and low FEV1 (0.027, 0.008; 0.001 and 0.001; 0.001, respectively). Logistical regression analysis of sex, age, diabetes mellitus, hypertension, cigarette smoking, family history, physical inactivity, and FEV values showed that physical inactivity was independently correlated with high CACS [odds ratio (OR): 7; confidence interval (CI): 3-20; p=0.001].Conclusion: The value of CACS is high in stage II COPD patients. Male stage II COPD patients with a disease duration of 10 years, physical inactivity, and/or a positive family history should be monitored for early stage coronary artery disease and coronary events, regardless of risk factors such as diabetes, hypertension, and hyperlipidemia

🔖

Cite This Article

ÖZYILMAZ, S. Ö., ALİŞİR, M. F., SERDAR, O. A., UZASLAN, E. (2016). The value of coronary artery calcium score in the early diagnosis of coronary artery disease in patients with stable chronic obstructive pulmonary disease. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 4, 283–289. https://ajindex.com/articles/365860

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Gan WQ, Man SF, Senthilselvan A, Sin D. Association between chronic obstructive pulmonary disease and systemic inflamma- tion: a systematic review and a metaanalysis. Thorax 2004; 59: 574-80.
  2. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension, and cardiovascular disease in chronic obstructive pulmonary disease. Eur Respir J 2008; 32: 962-9.
  3. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comor- bidities of COPD. Eur Respir J 2008; 31: 204-12.
  4. Schoen FJ, Levy RJ. Tissue heart valves: Current challenges and future research perspectives. J Biomed Mater Res 1999; 47: 439-65.
  5. Speer MY, Giachelli CM. Regulation of cardiovascular calcifica- tion. Cardiovasc Pathol 2004; 13: 63-70. Virchow R (eds). Cellular pathology. Images in historical medicine.150th edition. St. Pölten, Austria: Springer-Verlag; 2008.
  6. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, et al. Phosphate regulation of vascular smooth muscle celi calcifica- tion. Circ Res 2000; 87: 10-7.
  7. Trion A, Van der Laarse A. Vascular smooth muscle cells and calcification in atherosclerosis. Am Heart J 2004; 147: 808-14.
  8. Budoff MJ, Dowe D, Jollis JG, Gitter M, Sutherland J, Halamert E, et al. Diagnostic performance of 64- multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease. J Am Coll Cardiol 2008; 52: 1724-32.
  9. Reichek N, Kamel D, Pollack S, Voros S. Can segmental analysis of calcium score predict the likelihood of coronary artery steno- sis? J Am Coll Cardiol 2011; 57: 1129-206.
  10. Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley WG, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation 2005; 111: 682-96.
  11. Raggi P, Shaw JL, Berman SD, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. JACC 2004; 43: 1663-9.
  12. Kennedy J, Shavelle R, Wang S, Budoff M, Detrano RC. Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiography. Am Heart J 1998; 135: 696-702.
  13. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary eve